| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |